hydrochloride, a calcimimetic agent, is primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and primary hyperparathyroidism in patients who are not surgical candidates. The ability of this drug to modulate parathyroid hormone (PTH) levels is crucial in managing patients with endocrine and metabolic disorders.
Market overview
Cinacalcet...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian